Education
About Us
Working with TipRanks
Follow Us
New Portfolio - New Portfolio
BioBudha
New PortfolioIndividual Investor
Ranked #405,466 out of 793,704 TipRanks' Investors
Success Rate
290 out of 678
profitable transactions
profitable transactions
Average Return
2.81%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▼ 4.35%
6-Month Return▲ 17.97%
12-Month Return▼ 3.22%
YTD Return▼ 4.13%
Total Return▲ 49.73%
Best Trade
Bio
I am an recent individual investor, exploring, learning and refining my investment skills
Performance
26.01%0-26.01%
▼ 13.14%
▲ 2.34%
▼ 7.00%
Aug 2024
▲ 2.93%
▲ 2.10%
▼ 1.06%
Sep 2024
▲ 10.00%
▼ 0.89%
▲ 2.36%
Oct 2024
▲ 26.01%
▲ 5.96%
▲ 14.61%
Nov 2024
▲ 5.34%
▼ 2.41%
▲ 4.23%
Dec 2024
▲ 5.88%
▲ 2.69%
▲ 4.63%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 4.21%
Feb 2025
▲ 5.30%
▼ 4.02%
▼ 4.35%
Mar 2025
▼ 13.14%▲ 2.34%▼ 7.00%
▲ 2.93%▲ 2.10%▼ 1.06%
▲ 10.00%▼ 0.89%▲ 2.36%
▲ 26.01%▲ 5.96%▲ 14.61%
▲ 5.34%▼ 2.41%▲ 4.23%
▲ 5.88%▲ 2.69%▲ 4.63%
▼ 12.86%▼ 1.27%▼ 4.21%
▲ 5.30%▼ 4.02%▼ 4.35%
Recent Activity
POET Technologies
―
▼ 7.58%
2
Close
Sep 27, 2024
Palantir Technologies
9.53%
▲ 177.40%
2
Buy
Sep 24, 2024
Schwab US Dividend Equity ETF
11.18%
▲ 0.86%
6
Buy
Sep 24, 2024
Tesla
4.13%
▼ 2.87%
6
Buy
Sep 24, 2024
Meta Platforms
6.07%
▲ 7.05%
2
Buy
Sep 24, 2024
Vanguard S&P 500 Growth ETF
10.07%
▼ 0.04%
2
Buy
Sep 24, 2024
Vanguard Growth ETF
3.83%
▼ 0.15%
2
Buy
Sep 24, 2024
Nvidia
15.71%
▼ 7.79%
1
Open
Sep 24, 2024
Roblox
1.8%
▲ 26.30%
1
Open
Sep 24, 2024
Hookipa Pharma
―
▼ 95.79%
16
Close
Sep 23, 2024
Roundhill Sports Betting & iGaming ETF
―
▼ 36.76%
4
Close
Sep 23, 2024
ARK Fintech Innovation ETF
―
▼ 18.97%
14
Close
Sep 23, 2024
ARK Innovation ETF
―
▼ 17.89%
26
Close
Sep 23, 2024
ARK Space Exploration & Innovation ETF
―
▼ 23.96%
2
Close
Sep 23, 2024
Replimune Group
―
▼ 23.09%
8
Close
Sep 23, 2024
Invesco WilderHill Clean Energy ETF
―
▼ 24.44%
6
Close
Sep 23, 2024
Curis
―
▼ 96.45%
7
Close
Sep 23, 2024
Skillz
―
▼ 99.11%
2
Close
Sep 23, 2024
Scholar Rock Holding
―
▼ 80.83%
7
Close
Sep 23, 2024
Adaptimmune Therapeutics
―
▼ 82.73%
2
Close
Sep 23, 2024